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Type 2 inflammatory cytokines, including interleukin-
4 (IL-4), IL-5, IL-9, and IL-13, drive the characteristic
features of immunity against parasitic worms and
allergens. Whether IL-9 serves an essential role in
the initiation of host-protective responses is contro-
versial, and the importance of IL-9- versus IL-4-pro-
ducing CD4+ effector T cells in type 2 immunity is
incompletely defined. Herein, we generated IL-9-
deficient and IL-9-fluorescent reporter mice that
demonstrated an essential role for this cytokine in
the early type 2 immunity against Nippostrongylus
brasiliensis. Whereas T helper 9 (Th9) cells and type
2 innate lymphoid cells (ILC2s) were major sources
of infection-induced IL-9 production, the adoptive
transfer of Th9 cells, but not Th2 cells, caused rapid
worm expulsion, marked basophilia, and increased
mast cell numbers in Rag2-deficient hosts. Taken
together, our data show a critical and nonredundant
role for Th9 cells and IL-9 in host-protective type 2
immunity against parasitic worm infection.
INTRODUCTION
Naive T cell differentiation into the CD4+ T helper 2 (Th2) cell
subset is considered a central effector mechanism driving
adaptive host protection against parasitic helminths and the
pathophysiological sequelae of most allergic diseases (Palm
et al., 2012). However, the understanding of type 2 inflamma-
tion has recently increased in complexity in that it also
involves interleukin-9 (IL-9)-producing Th cell subsets (Th9
cells), type 2 innate lymphoid cells (ILC2s), and epithelial-cell-
derived cytokines (thymic stromal lymphopoietin [TSLP], IL-
25, and IL-33) (Allen and Maizels, 2011; Lloyd and Hessel,
2010; Paul and Zhu, 2010). Although type 2 inflammatory
mechanisms function in both humans and mice to promote
elevated IL-4, IL-5, IL-9, and IL-13 amounts and eosinophilia,
mastocytosis, basophilia, goblet cell metaplasia, and immuno-744 Immunity 39, 744–757, October 17, 2013 ª2013 Elsevier Inc.globulin E (IgE) production, the pathways responsible for initi-
ating these responses remain controversial (Pulendran and
Artis, 2012). Moreover, the functional redundancy among type
2 cytokines and effector mechanisms has generated consider-
able debate over which pathway, if any, serves an essential and
nonredundant function.
IL-9 is a prototypical type 2 cytokine implicated in human and
murine asthma, anaphylaxis, resistance to nematode infection,
antiviral immunity, and tumorigenesis (Dodd et al., 2009; Fallon
et al., 2000; Faulkner et al., 1997; Faulkner et al., 1998; Forbes
et al., 2008; Gessner et al., 1993; Knoops et al., 2005; Lu et al.,
2012; Osterfeld et al., 2010; Shimbara et al., 2000). IL-9 has
been reported to be mainly produced by T cells but can also
be produced by mast cells, eosinophils, and ILC2s (Gounni
et al., 2000; Hu¨ltner et al., 2000; Schmitt et al., 1989; Uytten-
hove et al., 1988; Wilhelm et al., 2011). IL-9 stimulates the
growth, proliferation, and survival of T cells, enhances the
production of IgE from B cells, promotes the proliferation and
differentiation of mast cells and hematopoietic progenitors,
and induces secretion of mucus and chemoattractant mole-
cules by mucosal epithelial cells (Dong et al., 1999; Gounni
et al., 2004; Petit-Frere et al., 1993; Uyttenhove et al., 1988;
Van Snick et al., 1989). Recent identification of Th9 cells as a
specialized Th cell subset secreting IL-9 in vitro has caused a
reevaluation of the natural sources of this cytokine in vivo.
Although previously considered to be a Th2-cell-derived cyto-
kine, IL-9 is produced as an effector cytokine by Th9 cells
(differentiated via transforming growth factor b [TGF-b] and
IL-4), Th17 cells (differentiated with TGF-b and IL-6), and
Foxp3+ T regulatory (Treg) cells (differentiated with TGF-b
alone) (Dardalhon et al., 2008; Elyaman et al., 2009; Lu et al.,
2006; Veldhoen et al., 2008). As such, whether Th9 cells serve
a distinct biological role that is not shared by other T cell line-
ages is currently unknown.
Cytokines released from distinct Th cell lineages dramatically
influence disease outcome, particularly in the context of para-
sitic helminth infections, which affect more than one billion peo-
ple worldwide (Brooker, 2010). Previous studies directed toward
elucidating the role of IL-9 in hookworm infection have sug-
gested a dispensable role for IL-9 in promoting worm clearance
(Townsend et al., 2000). However, other reports have supported
a protective role for IL-9 during Trichinella spiralis and Trichuris
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Figure 1. IL-9 Expression Precedes IL-4,
IL-5, and IL-13 Expression during
N. brasiliensis Infection
C57BL/6 mice were subcutaneously infected with
625 L3 N. brasiliensis larvae. MedLNs (A), lungs
(B), MLNs (C), and the small intestine (D) were
collected and homogenized at different days
p.i. for assessment of il9 mRNA expression by
real-time RT-PCR. MedLNs (E), lungs (F), MLNs
(G), and the small intestine (H) were analyzed
for Il4, Il5, and Il13 mRNA expression. Data
represent the mean ± SEM ratio of cytokine gene
expression to Hprt expression as determined by
the relative quantification method (DDCt). The
experiment was performed twice with similar
results with two to three mice per day p.i. Statis-
tically significant p values when comparing basal
expression (d0) and at least one other time point
for each gene were determined by one-way
ANOVA.
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Th9 Cells Promote Anti-helminth Immunitymuris infections (Faulkner et al., 1997; Faulkner et al., 1998;
Richard et al., 2000; Veldhoen et al., 2008). Thus, contradictory
evidence has made it difficult to conclude the real contribution
of IL-9 in the control of type 2 immune responses. In addition,
definitive evidence identifying the cellular sources of IL-9 in
infection models in vivo is still missing.
In this report, we investigated whether IL-9 is necessary and/
or sufficient for host-protective type 2 immunity in vivo. In both
mucosal tissues and secondary lymphoid organs,Nippostrongy-
lus brasiliensis infection induced IL-9 expression, which pre-
ceded IL-4, IL-5, and IL-13 expression at these sites. IL-9
deficiency abrogated canonical type 2 cytokine production,
basophilia, eosinophilia, mast cell amplification, and worm
expulsion. Furthermore, we produced a strain of IL-9-fluorescent
reporter mice and demonstrated that both CD4+ T cells and
ILC2s were major sources of IL-9 secretion upon infection.
When adoptively transferred into Rag2-deficient hosts, Th9 cellsImmunity 39, 744–757,were markedly more efficient than Th2
cells at driving basophilia, increased
mast cell numbers, and rapid worm
expulsion. Thus, our data show that IL-9
serves a critical role in the early stages
of type 2 immunity and that its production
from effector CD4+ T cells is alone suffi-
cient for host protection against worm
infection.
RESULTS
IL-9 Expression Precedes IL-4, IL-5,
and IL-13 Expression In Vivo
Rapid induction of type 2 cytokines is crit-
ical for host immunity against most para-
sitic helminthes, but whether distinct
cytokines are responsible for orches-
trating host protection remains unclear.
To gain a better understanding of type 2
cytokine regulation in vivo, we investi-gated the spatiotemporal expression patterns of IL-4, IL-5,
IL-9, and IL-13 during N. brasiliensis infection. Upon infection,
we found a strong induction of all type 2 cytokines, which are
otherwise low or undetectable at steady state. As expected,
the induction of these cytokines correlated with the presence
of the parasite in the different target organs and associated
lymphoid tissues; it peaked first in the lungs and later in the small
intestine (Figure 1). Comparison of mRNA expression in wild-
type (C57BL/6)-infected mice showed that IL-9 was the first
among these cytokines induced by N. brasiliensis infection.
IL-9 expression in mediastinal lymph nodes (medLNs) was de-
tected as early as day 2 postinfection (p.i.) (Figure 1A) and
peaked later around day 4 in the lungs (Figure 1B). In the mesen-
teric lymph nodes (MLNs), we observed the highest expression
at day 4 p.i. (Figure 1C) and a subsequent strong increase by
day 7 in the small intestine (Figure 1D). IL-9 expression was
strictly transient, suggesting a very tight control in the expressionOctober 17, 2013 ª2013 Elsevier Inc. 745
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Figure 2. Impaired Worm Expulsion in the Absence of IL-9
(A) Infected wild-type Il9+/+ (white bars) and null Il9/ (black bars) mice were sacrificed at day 7 p.i. for obtaining intestinal worm counts. Data represent the
mean ± SEM of six mice per group.
(B) At day 7 p.i, the lungs and small intestine (SI) of Il9+/+ (white bars) or Il9/ (black bars) infected mice were harvested and homogenized for assessment of Il4,
Il5, and Il13 mRNA expression. Data represent the mean ± SEM of cytokine gene expression to Hprt expression as determined by the DDCt method. Similar
results were obtained in two independent experiments with six mice per group.
(legend continued on next page)
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Th9 Cells Promote Anti-helminth Immunityof this cytokine in vivo, and was detected earlier than IL-4, IL-5,
and IL-13 expression in all tissues examined (Figures 1E–1H). In
the spleen, IL-9 expression also preceded that of IL-4, IL-5, and
IL-13 (Figure S1, available online). Thus, IL-9 is expressed early
upon helminth infection and could potentially act upstream of
other type 2 cytokines in vivo.
IL-9 Is Necessary for IL-5 and IL-13 Induction,
Eosinophilia, Basophilia, and Worm Clearance In Vivo
To investigate the role of IL-9 during the spontaneous develop-
ment of type 2 immunity against N. brasiliensis, we generated
IL-9-deficient mice on a BALB/c background through targeted
deletion of exons 1–4. The targeting vector contained a
neomycin (neo)-resistance cassette flanked by homology re-
gions upstream of exon 1 and downstream of exon 4 of Il9,
encoding IL-9 (Figure S2A). Genotyping of wild-type (+/+), het-
erozygous (+/), and homozygous null (/) mice by PCR is
shown in Figure S2B. IL-9-deficient mice were viable and fertile
and did not show any gross phenotypic abnormalities. Analysis
of the IL-9-deficient mice confirmed that Il9mRNA and IL-9 pro-
tein expression were undetectable in supernatants of sorted
naive CD4+ T cells polarized under Th9-cell-culture conditions
in vitro (Figure S2C and data not shown). During N. brasiliensis
infection, IL-9 deficiency had a negative impact on worm clear-
ance, shown by a significant increase in worm burden in Il9/
mice compared to wild-type mice at day 7 p.i. (Figure 2A).
Because we found that IL-9 was expressed in the early phase
ofN. brasiliensis infection, we sought to determine whether other
type 2 cytokines were affected in its absence. To this end, we
analyzed type 2 cytokine induction in this infectious setting.
We confirmed the absence of Il9 mRNA in IL-9-deficient mice
in vivo (Figure S2D). Compared to wild-type mice, IL-9-deficient
mice showed severely impaired Il5 and Il13mRNA expression in
the lungs and small intestine at day 7 p.i. (Figure 2B). Expression
of other type-2-related genes such as Gata3, Il10, and Il9r was
not affected by IL-9 deletion (data not shown). Infection of IL-
9-deficient mice with N. brasiliensis also resulted in a significant
reduction in the cellularity of the spleen andmedLNs at day 7 p.i.
In contrast, total lymphoid infiltrates in the MLNs and lungs were
not affected (Figure S2E). A detailed phenotypic analysis of the
infiltrate present in the target organs of Il9/ mice and wild-
type mice infected with N. brasiliensis showed a significant
decrease in the absolute numbers of eosinophils (CD11b+Siglec
F+) in all organs analyzed (Figure 2C). Unexpectedly, we also
found a significant decrease in basophilia (CD49b+FcεR+
c-Kit) in the spleen and lungs of Il9/mice (Figure 2D). Analysis
of other cell subsets, including neutrophils (CD11b+Ly6G+) and
ILC2s (linCD45+Thy1.2+Sca+c-Kit+CD44+), showed similar
numbers in affected tissues (Figures S2F and S2G and data
not shown). Consistent with previous findings reporting a role
for IL-9 in mast cell degranulation and goblet cell hyperplasia
(Townsend et al., 2000), mast cell metalloproteinase 1 (Mcpt1)
secretion in serum and mucin5b mRNA expression in the small(C) Total numbers of eosinophils (CD11b+Siglec F+) as determined by flow cytom
(black bars) mice at day 7 p.i. Data represent the mean ± SEM of experiments w
(D) Total numbers of basophils (CD49b+FceR+c-Kit) as determined by flow cyto
(black bars) mice at day 7 p.i. Data represent the mean ± SEM of experiments w
The p values determined by unpaired two-tailed Student’s t test between groupsintestine were reduced or absent in Il9/ infected mice (Figures
S2H and S2I). Mast cell numbers were also significantly
decreased in the lungs, MLNs, and spleen of Il9/ mice (Fig-
ure S2J). All together, our data support an important role for
IL-9 in the potentiation and orchestration of anti-helminthic re-
sponses in vivo.
Tracking of IL-9-Expressing Cells In Vivo with IL-9-
Fluorescent Reporter Mice
To identify the cellular sources of IL-9 in vivo, we generated IL-9
reporter knockin mice designated INFER (Interleukin Nine Fluo-
rescent Reporter) mice. Unlike the design in previous reports
using fate reporter transgenic mice (Wilhelm et al., 2011), our
design allows tracking of IL-9-expressing cells in real time. The
targeting design consisted of the insertion of an internal ribo-
somal entry site (IRES) followed by the coding sequence for
GFP (IRES-GFP) downstreamof the stop codon of Il9 (Figure 3A),
thus allowing for reporter expression induced by the endoge-
nous IL-9 promoter. The resulting mice were viable and fertile
and showed no gross phenotypic defects.
Initial characterization of the INFER mice demonstrated
that insertion of the IRES-GFP cassette into the Il9 locus did
not disrupt the endogenous expression of the gene or the pro-
tein. Kinetic analysis of Il9 mRNA expression in vitro demon-
strated that IL-9 peaked at day 3 and decreased by day 5 in
sorted naive CD4+ T cells differentiated in Th9 cell cultures
from INFER or wild-type mice. Measurement of IL-9 in the su-
pernatants of these cultures by ELISA also demonstrated
equivalent protein expression by day 5 (Figures S3A and
S3B). We consistently observed a 24 hr delay between the
peak of Il9 mRNA expression and IL-9 protein secretion
measured in supernatants of Th9 cell cultures in vitro. To vali-
date IL-9 production and GFP expression, we sorted naive
CD4+ T cells isolated from INFER mice and cultured them
in vitro for 5 days in polarizing conditions suited to generate
different effector Th cell subpopulations. Notably, GFP expres-
sion controlled by the endogenous IL-9 promoter occurred
mostly under Th9-cell-polarizing conditions and only a low fre-
quency of cells in Th2 and Th17 cell conditions (Figure 3B). We
confirmed by ELISA the specific induction of IL-9 in Th9-cell-
polarizing conditions and the respective cytokines in the
different cultures to validate the corresponding induction of
interferon-g (IFN-g), IL-4, and IL-17A in Th1, Th2, and Th17
cells, respectively (Figure 3C and data not shown). To further
demonstrate that GFP expression in Th9 cell cultures of INFER
naive CD4+ T cells corresponded to IL-9-producing cells, we
sorted GFP+ and GFP cells from day 5 cultures and analyzed
Il9 mRNA and IL-9 cytokine expression. Both Il9 mRNA and
IL-9 protein levels were significantly higher in GFP+ cells than
in GFP cells (Figure 3D and 3E). Moreover, intracellular stain-
ing performed in Th9 cell cultures with INFER naive T cells
in vitro demonstrated that 80% of the cells expressing IL-9
also expressed GFP (Figure S3C). Thus, we generated a tooletry in the lungs, medLNs, MLNs, and spleen of Il9+/+ (white bars) and Il9 /
ith six mice per group.
metry in the lungs, medLNs, MLNs, and spleen of Il9+/+ (white bars) and Il9/
ith six mice per group.
are shown.
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Figure 3. Generation of INFER Mice and Expression Analysis In Vitro
(A) A 7.8 kb genomic fragment of the Il9 locus was used for creating the targeting construct (middle), in which an IRES-GFP cassette followed by a loxP-flanked
neo resistance gene was inserted downstream of the stop codon. Deletion of neo by Cre recombinase resulted in the final targeted allele (bottom). Filled boxes
represent exons 1–5. loxP sites are shown as arrow heads. Restriction sites are depicted. TK stands for thymidine kinase.
(B) Sorted naive CD4+CD62L+CD25CD44 T cells from INFER mice were cultured for 5 days in Th0-, Th1-, Th2-, Th9-, Th17-, or Treg-cell-polarizing conditions
in vitro. Recovered cells were stained for surface CD4, and GFP expression was analyzed by flow cytometry. Numbers indicate the frequencies of CD4+GFP+
cells. The experiment was performed five times with similar results.
(C) Supernatants from cells isolated from cultures in (B) at day 5 were stimulated in vitro with anti-CD3 for 24 hr and analyzed by ELISA for IL-9 quantification. The
mean ± SEM from one out of three independent experiments measured in triplicate is shown.
(legend continued on next page)
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efficiently used for determining the source and function of this
cytokine in vivo.
IL-9 Is Expressed in CD4+ T Cells and ILC2s In Vivo
To determine the source of IL-9 during helminth infection, we in-
fected INFER mice with N. brasiliensis and analyzed GFP
expression at days 0, 3, 5, 7, and 10 p.i. We did not find detect-
able expression of IL-9 (measured as GFP) under steady-state
conditions in the spleen, lymph nodes, thymus, or bone marrow
of INFER mice (data not shown). GFP expression was detected
as early as day 3 p.i. in the medLNs, day 5 in the lungs, and later
by day 7 in the MLNs of infected INFER mice (Figures 4A and 4B
and Figures S4A and S4B). A detailed analysis demonstrated
that the observed GFP expression corresponded to CD4+
T cells and ILC2s. Quantification of GFP+ cells in the lungs
showed that CD4+GFP+ T cells increased from day 5 to day 7
p.i. However, there was a significant reduction by day 10 p.i.,
indicating transient expression of IL-9 in this cellular compart-
ment. In contrast, GFP+ ILC2s in the lungs increased by day 5
and were maintained throughout the analysis (Figure 4C). In
MLNs, we found a significant increase in CD4+ T cells and
ILC2s expressing GFP by day 7 p.i.; this increase was further
amplified by day 10 (Figure 4D). Importantly, the kinetics of IL-
9 GFP expression closely correlated with worm trafficking and
expulsion in most immunocompetent mouse strains. IL-9 GFP
was not significantly expressed in eosinophils or mast cells dur-
ing N. brasiliensis infection (data not shown). To definitively
prove that GFP+ cells corresponded to IL-9-expressing cells
in vivo, we sorted GFP+ and GFP CD4+ T cells or ILC2s from
the lungs and MLNs at day 10 p.i. GFP+CD4+ T cells and
GFP+ ILC2s expressed higher levels of IL-9 than did GFP cells
(Figures S4C and S4D); hence, GFP expression efficiently re-
ported IL-9-expressing cells in vivo. Thus, we used INFER
mice to demonstrate that during N. brasiliensis infection, Th9
cells, together with ILC2s, develop and represent the cellular
sources of IL-9 expression. The kinetic of IL-9 expression, as
well as the original source, changes over time and depends
on the presence of the relevant insult in vivo.
IL-9 Derived from CD4+ T Cells Is Sufficient to Promote
Host Protection against N. brasiliensis
Because ILC2s and CD4+ T cells produce IL-9 in vivo, we sought
to determine the contribution of IL-9 produced by CD4+ T cells
to host protection against N. brasiliensis. Thus, we transferred
Th9 cells generated in vitro into IL-9-deficient hosts in the
context of nematode infection. This experimental setting was
devoid of IL-9 produced from the innate compartment (i.e.,
ILC2s). In IL-9-deficient hosts, IL-9 derived from CD4+ T cells
was sufficient to promote a significant decrease in worm loads,
equivalent to wild-type levels (Figure 5A). Moreover, IL-13
expression, which was significantly reduced in the absence
of IL-9 (Figure 2B), increased to levels comparable to those of
wild-type mice in the small intestine upon reintroduction of(D) Sorted GFP or GFP+ cells from day 5 Th9 cell cultures with INFER naive CD4
normalized to Hprt is shown.
(E) GFP or GFP+ cells as described in (D) were stimulated with anti-CD3 for 24 hr.
mean ± SEM from one out of three independent experiments measured in triplicTh9 cells (Figure 5B). Likewise, IL-5 expression was partially
restored in the small intestine (Figure 5B). Interestingly, there
was no significant change in the levels of Il13 and Il5 mRNA be-
tween the lungs of Il9/ mice that received Th9 cells and those
of Il9/ mice that did not receive Th9 cells (Figure 5B). A partial
rescue was also observed in the numbers of eosinophils and
basophils in the lungs, MLNs, and spleen of IL-9-deficient
mice transferred with Th9 cells (Figures 5C and 5D). Thus,
although ILC2-derived IL-9 could play a critical role in the pro-
motion of optimal immune responses against nematodes, IL-9
derived from CD4+ T cells is sufficient to promote an effective
anti-helminth response in vivo.
Th9 Cells Promote Basophilia and Increased Mast Cell
Numbers, Leading to a Rapid Helminth Expulsion In Vivo
On the basis of our foregoing findings, we hypothesized that Th9
cells represent a protective subset of specialized effector Th
cells in vivo. To characterize the function of Th9 cells, we sought
to determine how the role of these cells compares to that of
classical Th2 cells during N. brasiliensis infection. To this end,
we adoptively transferred 2 3 105 purified effector Th9 or Th2
cells generated in vitro into immunodeficient Rag2 / recipient
mice and infected them 24 hr later with N. brasiliensis. We
analyzed the relevant tissues at days 5 and 7 p.i. To generate
effector Th9 and Th2 cells, we sorted naive CD4+ T cells from
INFER or IL-4 reporter 4get mice (Mohrs et al., 2001) and polar-
ized them toward Th9 or Th2 cells, respectively, for 5 days.
Sorted effector Th9 or Th2 cells (measured as GFP-expressing
cells in these cultures) were used for the transfer experiments.
Importantly, transfer of Th9 cells, but not Th2 cells, significantly
decreased the worm burden in recipient mice starting at day
5 p.i., which was also observed by day 7 p.i. (Figure 6A). Interest-
ingly, IL-9 expression on T cells promoted better engraftment of
the transferred cells observed in MLNs by day 5 p.i., which was
also recapitulated in the lungs and spleen by day 7 p.i. (Fig-
ure S5A). Despite increased eosinophilia observed in mice trans-
ferred with Th2 cells at day 7 p.i., we did not find important
differences between groups in the numbers of this subset in vivo
(Figure S5B), suggesting that the effect of Th9 cell transfer in
worm expulsion was independent of eosinophils. At day 7 p.i.,
Th9 cells promoted significantly increased mast cell and baso-
phil numbers in the lungs and spleen, but not MLNs, as well as
a significant concomitant increase in ILC2s in the spleen, of
Rag2/ recipient mice (data not shown) (Figures 6B and 6C).
On the basis of microarray data, it has been suggested that
ILC2s could directly respond to IL-9 (Price et al., 2010; Wilhelm
et al., 2012); similarly, IL-9 has been shown to act as a mast
cell growth factor (Hu¨ltner et al., 1990). However, there is no
report so far for IL-9R expression on basophils. To determine
whether basophils could represent a direct target for IL-9 in vivo,
we isolated lung-infiltrating basophils from day 7 infected mice
and analyzed Il9r mRNA expression. Indeed, basophils ex-
pressed Il9r mRNA, and this expression was lower than that in
mast cells but higher than that in eosinophils isolated from the+ T cells were examined for IL-9 expression by real-time RT-PCR. Mean ± SEM
Supernatants were collected and analyzed by ELISA for IL-9 quantification. The
ate is shown.
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(legend on next page)
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Th9 Cells Promote Anti-helminth Immunitysame tissue (Figure S6). Hence, the effect of IL-9 on basophilia
could be mediated directly in vivo.
Finally, to definitively prove that IL-9 was the effector cytokine
responsible for the Th9-cell-induced responses in vivo, we per-
formed transfer experiments in which we administered neutral-
izing antibodies against IL-9 during the course of the transfer
experiment. IL-9 neutralization ablated the decrease in worm
loads induced by Th9 cell transfers into Rag2/ recipient mice
(Figure 7A). In addition, Th9-cell-induced mast cell and basophil
amplification in the lungs and spleen was severely impaired in
mice treated with anti-IL-9, but not in mice treated with isotype
control (both groups of mice received effector Th9 cells) (Figures
7B and 7C). Thus, we demonstrated that IL-9 was strictly
required for Th9 cells to promote the phenotype observed
when transferred into immunocompromised hosts. All together,
these data indicate that Th9 cells, through the expression of
the effector cytokine IL-9, are more efficient than classical Th2
cells at orchestrating anti-helminth responses in vivo.
DISCUSSION
In this study, we identified a central and nonredundant role for
IL-9 in driving host-protective type 2 immunity against hook-
worm infection. Using our generated IL-9-deficient mice, we
found that IL-9 promotes IL-5 and IL-13 expression and in-
creases basophilia, eosinophilia, and mast cell numbers in para-
site-targeted tissues and ultimately leads to efficient worm
expulsion. Generation of IL-9-fluorescent reporter mice allowed
us to identify Th9 cells and ILC2s as natural sources of IL-9
in vivo. Both adaptive and innate IL-9-expressing subsets were
rapidly induced within mucosal and lymphoid tissues upon
N. brasiliensis infection. Furthermore, functional characterization
of Th9 cells in adoptive transfer experiments demonstrated that
Th9 cells are more efficient than Th2 cells at driving basophil and
mast cell amplification and thus leading to worm expulsion. Our
data also support IL-9 as a critical effector cytokine for Th9 cell
function. As a whole, this study centers IL-9 as an important
regulator driving mucosal type 2 immunity in vivo.
IL-9 has been reported as part of the type 2 cytokine effector
panel; however, initial attempts to dissect its contribution in hel-
minth infection did not demonstrate a significant role for this
cytokine in worm clearance or type 2 cytokine induction in vivo
(Townsend et al., 2000). Contradictory results regarding IL-9
function in the immune system have been described, perhaps
mainly because of differences in the mouse strain analyzed
and the disease model and experimental approaches employed
to neutralize or amplify IL-9 expression in vivo (Faulkner et al.,
1998; Richard et al., 2000). In this report, we demonstrated
that IL-9 works as an initiator and/or amplifier of type 2 re-
sponses in vivo by activating innate subsets and promoting the
expression of other type 2 cytokines, which further maintain an
active response.Figure 4. IL-9 Is Expressed in CD4+ T Cells and ILC2s during N. brasili
INFERmicewere subcutaneously infectedwith 625 L3N. brasiliensis larvae. Lungs
assessment of IL-9 expression by flow cytometry. Numbers represent the freque
column). Total numbers of CD4+ T cells (white bars) and ILC2s (black bars) ex
determined by flow cytometry are shown. Data represent the mean ± SEM from on
p values determined by unpaired two-tailed Student’s t test between days are sIL-9 was originally identified as a T-cell-derived cytokine
(Schmitt et al., 1994; Schmitt et al., 1989). Although allergen-
specific induction of IL-9 in peripheral-blood mononuclear cells
of atopic patients and in murine models of allergy have been re-
ported (Chang et al., 2010; Jones et al., 2012; Yao et al., 2011),
there is no report of IL-9 expression in T cells in vivo without a
requirement for ex vivo restimulation on isolated T cell popula-
tions. Studies have identified Th9 cells as a new Th cell subset
responsible for IL-9 expression in vitro (Dardalhon et al., 2008;
Veldhoen et al., 2008). Previous attempts to identify Th9 cells
in vivo by using fate mapping of IL-9 reporter mice did not
demonstrate IL-9-expressing T cells in a lung inflammation
model, mainly because of incomplete reporter activity (Wilhelm
et al., 2011). The generation of INFER mice in the present study
enabled the tracking of active IL-9-expressing cells in real time.
With this genetic tool, we were able to identify Th9 cells gener-
ated in vivo without the requirement of additional manipulation
for their detection.
We also found that N. brasiliensis infection induced a second
population of IL-9-expressing cells, identified as ILC2s. This
innate subpopulation is an important source of IL-5 and IL-13
in vivo (Ikutani et al., 2012; Moro et al., 2010; Neill et al., 2010;
Price et al., 2010; Saenz et al., 2010). IL-9-expressing ILC2s
have also been observed in a papain-induced lung-inflammation
model; however, this expression was transient and transitioned
to IL-5 and/or IL-13 expression over time (Wilhelm et al., 2011).
Our analysis of IL-9 expression in vivo confirmed that compared
to other type 2 cytokines, this cytokine is expressed early during
nematode infection (Faulkner et al., 1998); furthermore, IL-9
induction followed a strict temporal and compartmentalized
regulation that might be important for avoiding detrimental
effects of chronic exposure such as those observed in trans-
genic models (Temann et al., 1998). Even with these intrinsic lim-
itations related to the nature of IL-9 induction, we have now
demonstrated that both adaptive and innate sources of IL-9
are rapidly induced in response to helminth infection.
We further demonstrated that T-cell-derived IL-9 is sufficient to
decrease worm loads and significantly increase IL-13 and IL-5
expression in the small intestine of IL-9-deficient mice.Moreover,
IL-9 derived fromCD4+ T cells induces significant increases in the
levels of eosinophils and basophils in multiple organs. Interest-
ingly, most of these parameters were only partially restored to
wild-type levels upon Th9 adoptive transfer, suggesting that
ILC2-derived IL-9 might be indispensable to amplify the immune
response in infected mice. These results support the notion of a
compartmentalized function for different sources of this cytokine
in vivo, and theexact contributionof the innate IL-9+ compartment
warrants further investigation.Nevertheless, the resultspresented
here clearly demonstrate that IL-9 producedbyT cells is sufficient
to efficiently orchestrate anti-helminth responses in vivo.
Because there has been recent controversy regarding the
function of T cells expressing IL-9, we focused our studyensis Infection
(A) andMLNs (B) were harvested and homogenized at different days p.i. for the
ncies of total GFP+ cells (left column) or GFP+ cells among CD4+ T cells (right
pressing IL-9 (GFP+) in the lungs (C) or MLNs (D) of INFER infected mice as
e out of three independent experiments with three to four mice per day p.i. The
hown.
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Figure 6. Adoptive Transfer of Th9Cells, but
Not Th2 Cells, Improves Worm Expulsion
(A) Sorted effector Th2 or Th9 cells (CD45.2+GFP+)
from day 5 in vitro cultures with naive CD4+
T cells isolated from 4get or INFER mice
were intravenously transferred into CD45.1+
Rag2/ recipient mice. After 24 hr, mice
were subcutaneously infected with 625 L3
N. brasiliensis larvae. As a control, a third group of
Rag2/ mice that did not receive T cells was also
infected. Worm counts in the small intestine at
days 5 (white bars) and 7 (black bars) p.i. are
shown.
(B) Total mast cell numbers in the lungs, MLNs,
and spleen of mice described in (A) as determined
by flow cytometry.
(C) Total basophil numbers in the lungs,MLNs, and
spleen of mice described in (A) as determined by
flow cytometry.
Data represent the mean ± SEM. The experiment
was repeated three times with similar results with
four to five mice per group. Statistics were calcu-
lated by an unpaired two-tailed Student’s t test.
The p values between groups are shown.
Immunity
Th9 Cells Promote Anti-helminth Immunityon whether Th9 cells represent a bona fide protective T cell
subset in N. brasiliensis infection. Although growing evidence
suggests that an IL-9-expressing T cell could account for
diverse immune responses in vivo, functional characterization
of purified Th9 cells has not been thoroughly addressed.Figure 5. T-Cell-Derived IL-9 Is Sufficient to Promote Worm Expulsion in IL-9-Deficient Hosts
(A) Sorted effector Th9 cells (GFP+) fromday 5 in vitro cultures with naive CD4+ T cells isolated from INFERmice
mice (gray bars). After 24 hr, mice were subcutaneously infected with 625 L3N. brasiliensis larvae. For compa
that did not received Th9 cells were used. Worm counts in the small intestine at day 7 p.i. are shown.
(B) At day 7 p.i., the lungs and small intestine (SI) of mice described in (A) were harvested and homogenized for
represent the mean ± SEM ratio of cytokine gene expression to Hprt expression as determined by the DD
independent experiments with six mice per group.
(C) Total eosinophil numbers in the lungs, MLNs, and spleen of mice described in (A) as determined by flow
(D) Total basophil numbers in the lungs, MLNs, and spleen of mice described in (A) as determined by flow c
Data represent the mean ± SEM. The experiment was repeated three times with similar results with five to s
unpaired two-tailed Student’s t test. The p values between groups are shown.
Immunity 39, 744–757,Phenotypic characterization of Th9 cells
in vivo has been done with heteroge-
neous populations of naive CD4+
T cells polarized toward Th9 cells
in vitro (Dardalhon et al., 2008; Purwar
et al., 2012; Staudt et al., 2010), where
contaminating cells not expressing IL-9
are unavoidable. Our generated mouse
model enabled us to study a pure pop-
ulation of IL-9-expressing T cells and
its function in a physiological setting
in vivo. With this approach, we have
now demonstrated that Th9 cells pro-
vide better protection to N. brasiliensis
infection than do classical Th2 cells,
supporting a specialized role for this
Th cell subset in vivo (Jones et al.,
2012; Staudt et al., 2010).Increased basophilia in Rag2/ mice transferred with T cells
during nematode infection has been previously reported (Min
et al., 2004). We have now demonstrated that this characteristic
phenotype is dependent on IL-9 expression by CD4+ T cells.
Similarly, we have demonstrated that the phenotype observedwere intravenously transferred into Il9/ recipient
rison, Il9+/+ (white bars) and Il9/ (black bars) mice
assessment of Il5 and Il13mRNA expression. Data
Ct method. Similar results were obtained in three
cytometry.
ytometry.
ix mice per group. Statistics were calculated by an
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Figure 7. IL-9 Neutralization Abrogates the
Th9-Cell-Induced Phenotype in Rag2–/–
Recipient Mice
Sorted effector Th9 cells (CD45.2+GFP+) from
day 5 in vitro cultures with naive CD4+ T cells
isolated from INFER mice were intravenously
transferred into CD45.1+Rag2/ recipient mice
treated with anti-IL-9 mAb (gray bars) or isotype
control (black bars). After 24 hr, mice were sub-
cutaneously infected with 625 L3 N.brasiliensis
larvae. As additional controls, mice without trans-
ferred cells but treated with anti-IL-9 (checkered
bars) or isotype control (white bars) were used.
(A) Worm counts in the small intestine of mice
described above at day 7 p.i.
(B) Total mast cell numbers in the lungs and spleen
of mice described above as determined by flow
cytometry.
(C) Total basophil numbers in the lungs and spleen
of mice described above as determined by flow
cytometry.
Data represent the mean ± SEM. The experi-
ment was repeated three times with similar
results with four to five mice per group. Statistics
were calculated by an unpaired two-tailed Stu-
dent’s t test. The p values between groups are
shown.
Immunity
Th9 Cells Promote Anti-helminth Immunityin Th9 cell recipient mice on mast cell amplification is also
dependent on IL-9, supporting the concept that IL-9 is a potent
mast cell growth factor (Camberis et al., 2003; Hu¨ltner et al.,
1990; Jones et al., 2012). In the future, the use of novel murine
models for analyzing the specific role of basophils in vivo will
be important for determining the contribution of IL-9 production
by Th9 cells to basophil expansion and activation during nema-
tode infection (Ohnmacht et al., 2010; Wada et al., 2010). Simi-
larly, the development of new experimental tools will be critical
for dissecting the effects of IL-9 on other cell types, such as
ILC2s and nonhematopoietic cells, such as mucosal epithelial
cells (Gounni et al., 2004). Our present findings regarding ILC2
amplification induced by Th9 transfer are particularly relevant
given that ILC2s and T cells seem towork in concert to potentiate
and induce robust N. brasiliensis elimination (Neill et al., 2010).
An interesting observation is that Il9r is one of the genes most
highly expressed on the ILC2 subpopulation (Price et al.,
2010). On the basis of this observation, we propose that T-cell-754 Immunity 39, 744–757, October 17, 2013 ª2013 Elsevier Inc.derived IL-9 could potentially account
for the increased ILC2 numbers observed
inRag2/ recipients transferred with Th9
cells.
In conclusion, our work indicates that
IL-9 from both innate and adaptive sour-
ces orchestrates and amplifies type 2 im-
munity. Importantly, Th9 cells, but not Th2
cells, promote effective anti-helminth re-
sponses in vivo, supporting the fact that
Th9 cells have specialized functions
that are strictly dependent on IL-9 and
that are not shared with those of other
Th cell subsets. Future studiesmonitoringIL-9 expression with INFERmicewill facilitate the identification of
the relevant sources and functions of IL-9 in vivo not only in
different type 2 immune responses, such as asthma, but also
in other IL-9-driven inflammatory disorders.
EXPERIMENTAL PROCEDURES
Mice
For the generation of IL-9-deficientmice, a genomic region containing exons 1–
4 of Il9 was deleted and substituted for the neo resistance gene. The targeting
construct contained 1.2 and 2.8 kb homology arms flanking the neo cassette.
Downstream of the 30 homology arm, the thymidine kinase gene was inserted
for additional screening (Figure S2). The linearized vector was electroporated
into BALB/c embryonic stem cells. G418-resistant, gancyclovir-sensitive
clones were screened and injected into C57BL/6 blastocysts. Chimeric males
in which germline transmission was successful were bred to BALB/c mice for
more than ten generations. Screening of Il9/ mice with primers 50-CAGGAT
GATTGTACCACACCG-30 and 50-CTCATTTGCTTGGATGTGAGC-30 or 50-TC
GCCTTCTTGACGAGTTCT-30 and 50-CCAACAGGTGGAGAGAAGACA-30
amplified a 250 bp wild-type allele or a 480 bp targeted allele, respectively.
Immunity
Th9 Cells Promote Anti-helminth ImmunityINFER mice were generated with a standard cloning strategy. In brief, the
targeting construct was generated by standard subcloning techniques using
appropriate restriction enzymes and the parental vectors pEasyflox and
pMCSV2.2. The targeting construct contained two homology arms of 1.9
and 4.4 kb. The IRES-GFP was introduced immediately after the stop codon
for avoiding disruption of cis-regulatory elements in the 30 UTR and the polya-
denylation signal. In addition, the construct contained a neo gene flanked by
loxP sites and driven by a promoter that allowed for positive selection in
both bacterial and mammalian cells (Figure 3). The targeting construct was
electroporated in JM8 embryonic stem cells derived from the purebred
C57BL/6 background, and individual clones were tested for successful homol-
ogous recombination by PCR. Embryonic stem cells carrying the targeted
allele were injected into BALB/c blastocysts, which were then implanted in
CD1 pseudopregnant foster mothers. Male chimeras were bred with the EIIa
Cre germline deleter (C57BL/6) strain (Jackson Laboratories) for removal of
the neo cassette and screening for germline-transmitted offspring. Mice
bearing the targeted allele were screened by PCR. Primers for the wild-type
allele, 50-GGGACGTTCCAGAAGACAGA-30 and 50-CCAAAAGCAACTGT
GAAGCA-30, amplified a 179 bp product. Primers for targeted allele, 50-
GGGACGTTCCAGAAGACAGA-30 and 50-GGAAAGACCCCTAGGAATGC-30,
amplified a 228 bp product. For transfer experiments into Il9/ mice, donor
cells from INFER mice backcrossed at least eight generations (N8) into
BALB/c background were used.
C57BL/6 and BALB/c mice were purchased from the National Cancer Insti-
tute, and Rag2 / mice on the C57BL/6 background (Taconic) and IL-4 re-
porter 4get mice (Mohrs et al., 2001) (Jackson Laboratories) were backcrossed
for more than ten generations to the C57BL/6 background in house.
All mouse experiments were approved by the Institutional Animal Care and
Use Committee of Yale University.
Helminth Infection
Individual mice were inoculated subcutaneously with 625 viable third-stage
N. brasiliensis larvae. Animals were sacrificed at different time points p.i.,
and harvested tissues were snap frozen for mRNA analysis or processed for
flow cytometry staining. Worm burdens were determined as described (Cam-
beris et al., 2003), and serum was collected.
Lymphocyte Preparation and Flow Cytometry
Spleen, medLNs, and MLNs were removed from euthanize mice, placed into
RPMI media supplemented with 5% fetal calf serum (FCS), and passed
through a cell strainer (70 mm). For isolation of lung infiltrates, cells were
collected after 1 hr digestion in RPMI media supplemented with 5% FCS,
1 mg/ml Collagenase D (Roche), and 10 mg/ml DNase I (Invitrogen) at 37C.
Homogenates were passed through a cell strainer, and infiltrates were sepa-
rated with a 27.5% Optiprep gradient (Axis-Shield) by centrifugation at
2,750 rpm for 20 min. Cells were removed from the interface, and ammo-
nium-chloride-potassium lysing buffer was used. Cells were acquired on an
LRS II Flow Cytometer (BD Biosciences), and data were analyzed with FlowJo
software (Tree Star).
For intracellular IL-9 staining, day 5 Th9 cell cultures were restimulated for
4 hr with phorbol 12-myristate 13-acetate (20 ng/ml) and ionomycin
(1 mg/ml) in the presence of brefeldrin A (1 mg/ml).
Antibodies
All antibodies for flow cytometry analysis were from eBioscience. For the lin
cocktail, biotin-coupled antibodies against CD4, CD8, CD11b, CD11c, CD19,
NK1.1, B220, Gr-1, Ter119, TCRgd, and TCRb were used. Fluorescent-
coupled streptavidin or antibodies against CD4, CD8, CD11b, CD25, CD44,
CD45, CD45.1, CD45.2, CD49b, CD62L, Thy1.2, Sca-1, c-kit, Ly6G, FcεR,
and Siglec-F were used. For intracellular staining, anti-IL-9-PE (BD) and anti-
GFP (Invitrogen) were used. For ELISA, purified and biotinylated antibodies
(BD Biosciences) against IFN-g, IL-4, IL-9, and IL-17 were used.
For neutralization experiments, anti-murine IL-9 (9C1) and an isotype control
(C1.18.4) from BioXcell were used.
In Vitro T Cell Differentiation
CD4+ T cells from the spleen and axillary and inguinal lymph nodes of C57BL/6,
INFER, or 4get mice were enriched by magnetic-activated cell sorting usinganti-CD4 beads (Milteny Biotech). Then, naive CD4+ T cells (CD25CD62L+
CD44) were purified by flow cytometry sorting and cultured in Clicks medium
(Sigma-Aldrich) supplemented with 10% FCS, L-glutamine (2 mM), penicillin
(100 U/ml), streptomycin (100 mg/ml), and b-mercaptoethanol (40 nM) in the
presence of plate-bound anti-CD3 (2C11, 2 mg/ml for Th2 and Th9 cells,
5 mg/ml for Th1 and Treg cells, 10 mg/ml for Th17 cells) and anti-CD28
(37N51, 10 mg/ml for Th2 and Th9 cells, 2 mg/ml for Th1 and Treg cells, 2 mg/
ml for Th17 cells with soluble antibody). A total of 0.75 3 10 6 cells/ml were
cultured for 5 days under Th1-, Th2-, Th9-, Th17-, or Treg-cell-polarizing con-
ditions. Cytokines for effector differentiation were as follows: Th1 cells: IL-12
(10 ng/ml PeproTech), anti-IL-4 (10 mg/ml, 11B11), and IL-2 (20 U/ml,
PeproTech); Th2 cells: IL-4 (20 ng/ml, PeproTech), anti-IFN-g (10 mg/ml,
XMG1.2), and IL-2 (20 U/ml); Th9 cells: IL-4 (10 ng/ml), TGF-b (1 ng/ml, R&D),
IL-1b (10 ng/ml, PeproTech), IL-25 (20 ng/ml, R&D), TSLP (50 ng/ml,
PeproTech), and anti-IFN-g (10 mg/ml); Th17 cells: TGF-b (0.5 ng/ml), IL-6
(20 ng/ml), IL-23 (50 ng/ml), anti-IL-4 (10 mg/ml), anti-IFN-g (10 mg/ml), and
anti-CD28 (5 mg/ml); and Treg cells: TGF-b (2 ng/ml).
Adoptive-Transfer Experiments
Naive CD4+ T cells (CD25CD62L+CD44) from 4get or INFER mice were
cultured in Th2- or Th9-cell-skewing conditions, respectively. On day 5, in-
vitro-generated effector cells were sorted by flow cytometry on the basis of
GFP expression. A total of 2 3 105 IL-4 GFP+ Th2 cells or IL-9 GFP+ Th9 cells
were transferred intravenously into CD45.1 Rag2/ recipient mice. CD45.2
expression on transferred cells was used for identifying donor cells. One day
after transfer, mice were infected with N. brasilienisis as described above
and euthanized for analysis 5–7 days p.i.
Transfer experiments with neutralizing antibodies against IL-9 were per-
formed as described above with Th9 cells. Mice were intravenously (first two
doses) or intraperitoneally injected with 200 mg/dose of antibody every other
day starting at day 2. Mice were euthanized for analysis at day 7 p.i.
For transfer experiments into Il9/ mice, 5 3 105 sorted Th9 cells (GFP+)
from day 5 cultures were used. One day later, transfered mice were infected
with N. brasilienisis as described above and euthanized for analysis at day
7 p.i.
Real-Time RT-PCR
RNA from cells or organs was extracted with Trizol reagent (Invitrogen) and
reverse transcribed with Superscript II (Invitrogen) and oligo dT according to
the manufacturer’s protocol. cDNA was semiquantitated with commercially
available TaqMan primer and probe sets with the use of the ABI-PRISM
7500 Sequence Detection System (Applied Biosystems). Expression was
calculated with the DDCt method normalized to Hprt expression.
Cytokine and mMCPT-1 Measurements
Cells from day 5 Th cell cultures in vitro were harvested and directly recultured
or cultured after sorting based onGFP expression in anti-CD3 (10 mg/ml) plate-
bound culture dishes. Cells were resuspended at 13 106 to 23 106 cells/ml in
Click’s media, and supernatants were collected 24 hr later for determining
cytokine concentration by ELISA. For mMCPT-1 quantification, serum from
mice infected with N. brasilienisis was collected at day 7 p.i. and analyzed
according to the manufacturer’s protocol (eBioscience).
Statistical Analysis
Statistical analyses were calculated in Prism 5.0 (Graphpad Software) with the
use of a two-tailed Student’s t test or one-way ANOVA; p% 0.05 was consid-
ered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and can be found with this
article online at http://dx.doi.org/10.1016/j.immuni.2013.07.020.
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